Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis.

Takafumi Yanagisawa; Pawel Rajwa; Constance Thibault; Giorgio Gandaglia; Keiichiro Mori; Tatsushi Kawada; Wataru Fukuokaya; Sung Ryul Shim; Hadi Mostafaei; Reza Sari Motlagh; Fahad Quhal; Ekaterina Laukhtina; Maximilian Pallauf; Benjamin Pradere; Takahiro Kimura; Shin Egawa; Shahrokh F Shariat

doi:10.1016/j.eururo.2022.08.002

Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis.

Takafumi Yanagisawa
, Pawel Rajwa
, Constance Thibault
, Giorgio Gandaglia
, Keiichiro Mori
, Tatsushi Kawada
, Wataru Fukuokaya
, Sung Ryul Shim
, Hadi Mostafaei
, Reza Sari Motlagh
, Fahad Quhal
, Ekaterina Laukhtina
, Maximilian Pallauf (Co-Autor/-in)
, Benjamin Pradere
, Takahiro Kimura
, Shin Egawa
, Shahrokh F Shariat

Universitätsklinik für Urologie und Andrologie

Publikation: Beitrag in Fachzeitschrift › Übersichtsarbeit › Begutachtung

88 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	584-598
Fachzeitschrift	EUROPEAN UROLOGY
Jahrgang	82
Ausgabenummer	6
DOIs	https://doi.org/10.1016/j.eururo.2022.08.002
Publikationsstatus	Veröffentlicht - 2022

Zugriff auf Dokument

10.1016/j.eururo.2022.08.002

Dieses zitieren

Yanagisawa, T., Rajwa, P., Thibault, C., Gandaglia, G., Mori, K., Kawada, T., Fukuokaya, W., Shim, S. R., Mostafaei, H., Motlagh, R. S., Quhal, F., Laukhtina, E., Pallauf, M., Pradere, B., Kimura, T., Egawa, S., & Shariat, S. F. (2022). Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis. EUROPEAN UROLOGY , 82(6), 584-598. https://doi.org/10.1016/j.eururo.2022.08.002

Yanagisawa, Takafumi ; Rajwa, Pawel ; Thibault, Constance et al. / Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis. in: EUROPEAN UROLOGY 2022 ; Jahrgang 82, Nr. 6. S. 584-598.

@article{0893aa944e414b07897db9799d539b61,

title = "Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis.",

keywords = "PHASE-III, SURVIVAL, MEN",

author = "Takafumi Yanagisawa and Pawel Rajwa and Constance Thibault and Giorgio Gandaglia and Keiichiro Mori and Tatsushi Kawada and Wataru Fukuokaya and Shim, \{Sung Ryul\} and Hadi Mostafaei and Motlagh, \{Reza Sari\} and Fahad Quhal and Ekaterina Laukhtina and Maximilian Pallauf and Benjamin Pradere and Takahiro Kimura and Shin Egawa and Shariat, \{Shahrokh F\}",

note = "Pallauf: Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Paracelsus Medical University Salzburg, University Hospital Salzburg, Salzburg, Austria.",

year = "2022",

doi = "10.1016/j.eururo.2022.08.002",

language = "English",

volume = "82",

pages = "584--598",

journal = "EUROPEAN UROLOGY ",

issn = "0302-2838",

publisher = "Elsevier ",

number = "6",

}

Yanagisawa, T, Rajwa, P, Thibault, C, Gandaglia, G, Mori, K, Kawada, T, Fukuokaya, W, Shim, SR, Mostafaei, H, Motlagh, RS, Quhal, F, Laukhtina, E, Pallauf, M, Pradere, B, Kimura, T, Egawa, S & Shariat, SF 2022, 'Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis.', EUROPEAN UROLOGY , Jg. 82, Nr. 6, S. 584-598. https://doi.org/10.1016/j.eururo.2022.08.002

Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis. / Yanagisawa, Takafumi; Rajwa, Pawel; Thibault, Constance et al.
in: EUROPEAN UROLOGY , Jahrgang 82, Nr. 6, 2022, S. 584-598.

Publikation: Beitrag in Fachzeitschrift › Übersichtsarbeit › Begutachtung

TY - JOUR

T1 - Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis.

AU - Yanagisawa, Takafumi

AU - Rajwa, Pawel

AU - Thibault, Constance

AU - Gandaglia, Giorgio

AU - Mori, Keiichiro

AU - Kawada, Tatsushi

AU - Fukuokaya, Wataru

AU - Shim, Sung Ryul

AU - Mostafaei, Hadi

AU - Motlagh, Reza Sari

AU - Quhal, Fahad

AU - Laukhtina, Ekaterina

AU - Pallauf, Maximilian

AU - Pradere, Benjamin

AU - Kimura, Takahiro

AU - Egawa, Shin

AU - Shariat, Shahrokh F

N1 - Pallauf: Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Paracelsus Medical University Salzburg, University Hospital Salzburg, Salzburg, Austria.

PY - 2022

Y1 - 2022

KW - PHASE-III

KW - SURVIVAL

KW - MEN

U2 - 10.1016/j.eururo.2022.08.002

DO - 10.1016/j.eururo.2022.08.002

M3 - Review article

C2 - 35995644

SN - 0302-2838

VL - 82

SP - 584

EP - 598

JO - EUROPEAN UROLOGY

JF - EUROPEAN UROLOGY

IS - 6

ER -

Yanagisawa T, Rajwa P, Thibault C, Gandaglia G, Mori K, Kawada T et al. Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis. EUROPEAN UROLOGY . 2022;82(6):584-598. doi: 10.1016/j.eururo.2022.08.002